Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

44.18
+0.89002.06%
Post-market: 44.180.00000.00%19:30 EDT
Volume:1.25M
Turnover:54.92M
Market Cap:4.80B
PE:-23.88
High:44.68
Open:43.54
Low:43.00
Close:43.29
52wk High:48.40
52wk Low:13.69
Shares:108.60M
Float Shares:88.17M
Volume Ratio:0.94
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8502
EPS(LYR):-1.6302
ROE:-38.03%
ROA:-25.03%
PB:10.71
PE(LYR):-27.10

Loading ...

Edgewise Therapeutics: on Track to Report 12-Week Cirrus-HCM Part D Data in Q2 2026

THOMSON REUTERS
·
Jun 01

Servier to buy Edgewise muscular dystrophy business for up to $2.65 billion

Reuters
·
Jun 01

Edgewise Therapeutics - Proceeds Expected to Fully Fund Edg-7500 Development Through Potential Approval

THOMSON REUTERS
·
Jun 01

Press Release: Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

Dow Jones
·
Jun 01

Analysts Are Bullish on Top Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 26

Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi Year Shareholder Returns

Simply Wall St.
·
May 20

Edgewise Therapeutics to present at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 12

Stifel Nicolaus Remains a Hold on Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 11

Edgewise Therapeutics' Update for EDG-7500 Could Boost Shares, RBC Says

MT Newswires Live
·
May 09

Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI

TIPRANKS
·
May 09

H.C. Wainwright Sticks to Its Buy Rating for Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 08

Edgewise Therapeutics Shares Decline Amid Wider Q1 Loss

MT Newswires Live
·
May 07

Edgewise Therapeutics reports Q1 EPS (46c), consensus (49c)

TIPRANKS
·
May 07

Edgewise Therapeutics Q1 EPS $(0.46) Beats $(0.50) Estimate

Benzinga Earnings
·
May 07

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q1 Net Loss $0.46 a Share, vs. FactSet Est of $0.49 Net Loss a Share

MT Newswires Live
·
May 07

Edgewise net loss widens to $49 million in Q1 FY26

Reuters
·
May 07

BRIEF-Edgewise Therapeutics Q1 Operating Expenses USD 54.115 Million

Reuters
·
May 07

Edgewise Therapeutics Q1 Operating Income USD -54.115 Million

THOMSON REUTERS
·
May 07

Press Release: Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications

Dow Jones
·
May 07

Why Edgewise Therapeutics (EWTX) Is Up 21.5% After Positive Trial, FDA Updates And Equity Grants

Simply Wall St.
·
May 07